ALEXANDRIA, Va., March 19 -- United States Patent no. 12,252,526, issued on March 18, was assigned to HUNAN YUANPIN CELL TECHNOLOGY Co. LTD. (Changsha, China).

"TCR-enriched clonotype, acquisition method and use thereof" was invented by Zhigang Xue (Hunan, China), Jinfeng Xue (Hunan, China), Ning Yi (Hunan, China), Bo Lv (Hunan, China), Chanyi Li (Hunan, China), Lingbin Qi (Hunan, China) and Weilin Li (Hunan, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are TCR-enriched clonotypes, and an acquisition method and use thereof. Amino acid sequences of the TCR-enriched clonotypes are: CAANRGSGYSTLTF (SEQ ID NO: 1)_CSARGERGEKLFF (SEQ ID NO: 2), CASSSGGSYIPTF (SEQ ID NO: 3)_CASSLAGGHETQYF (SEQ ID ...